Out for Blood: Tyler Shultz and Theranos

Jared D. Harris, Samuel L. Slover, Bradley R. Agle, George W. Romney, Jenny Mead, Jimmy Scoville
{"title":"Out for Blood: Tyler Shultz and Theranos","authors":"Jared D. Harris, Samuel L. Slover, Bradley R. Agle, George W. Romney, Jenny Mead, Jimmy Scoville","doi":"10.1108/case.darden.2024.000440","DOIUrl":null,"url":null,"abstract":"In early 2014, recent Stanford University graduate Tyler Shultz was in a quandary. He had been working at Theranos, a blood-diagnostic company founded by Elizabeth Holmes, a Stanford-dropout wunderkind, for almost a year. Shultz had learned enough about the company to realize that its practices and the efficacy of its much-touted finger-prick blood-testing technology were questionable and that the company was going to great lengths to hide this fact from the public and from regulators.Theranos and Holmes were Silicon Valley darlings, enjoying positive press and lavish attention from potential investors and technology titans alike. Just as companies like PayPal had revolutionized the stagnant payments industry and Uber had upended the for-hire transportation sector, Theranos had been positioned as the latest technology firm to substantially disrupt yet another mature sector: the medical laboratory business. By the start of 2014, the company had raised more than $400 million in funding, and had an estimated market valuation of $9 billion.Shultz's situation was exacerbated by the fact that his grandfather, the highly respected former US Secretary of State George Shultz, was on the Theranos board and was one of Elizabeth Holmes's biggest supporters.But Tyler Shultz worried about the customers he was convinced were receiving highly unreliable and often inaccurate blood-test results. With so much at stake, Shultz wondered how he should proceed. Should he raise his concerns with the firm's investors? Blow the whistle externally? Report to industry regulators? Go away quietly?This case and its subsequent four brief follow-up cases are based largely on interviews with Tyler Shultz, and outline the dilemma he faced and the various steps he would take both to extricate himself from his unsavory position and let the public know the full extent of the deception at Theranos.Five optional handouts are available to instructors to further discussion after the case has been debriefed. The handouts serve as additional decision points for the students if your class time permits.","PeriodicalId":247146,"journal":{"name":"Darden Business Publishing Cases","volume":"56 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Darden Business Publishing Cases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1108/case.darden.2024.000440","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

In early 2014, recent Stanford University graduate Tyler Shultz was in a quandary. He had been working at Theranos, a blood-diagnostic company founded by Elizabeth Holmes, a Stanford-dropout wunderkind, for almost a year. Shultz had learned enough about the company to realize that its practices and the efficacy of its much-touted finger-prick blood-testing technology were questionable and that the company was going to great lengths to hide this fact from the public and from regulators.Theranos and Holmes were Silicon Valley darlings, enjoying positive press and lavish attention from potential investors and technology titans alike. Just as companies like PayPal had revolutionized the stagnant payments industry and Uber had upended the for-hire transportation sector, Theranos had been positioned as the latest technology firm to substantially disrupt yet another mature sector: the medical laboratory business. By the start of 2014, the company had raised more than $400 million in funding, and had an estimated market valuation of $9 billion.Shultz's situation was exacerbated by the fact that his grandfather, the highly respected former US Secretary of State George Shultz, was on the Theranos board and was one of Elizabeth Holmes's biggest supporters.But Tyler Shultz worried about the customers he was convinced were receiving highly unreliable and often inaccurate blood-test results. With so much at stake, Shultz wondered how he should proceed. Should he raise his concerns with the firm's investors? Blow the whistle externally? Report to industry regulators? Go away quietly?This case and its subsequent four brief follow-up cases are based largely on interviews with Tyler Shultz, and outline the dilemma he faced and the various steps he would take both to extricate himself from his unsavory position and let the public know the full extent of the deception at Theranos.Five optional handouts are available to instructors to further discussion after the case has been debriefed. The handouts serve as additional decision points for the students if your class time permits.
血债血偿泰勒-舒尔茨与 Theranos
2014 年初,刚从斯坦福大学毕业的泰勒-舒尔茨陷入了困境。他在血液诊断公司 Theranos 工作了将近一年,该公司由斯坦福大学辍学生伊丽莎白-霍姆斯(Elizabeth Holmes)创办。舒尔茨已经对这家公司有了足够的了解,意识到它的做法及其大肆吹嘘的指尖验血技术的有效性是有问题的,而且该公司正在不遗余力地向公众和监管机构隐瞒这一事实。Theranos 和霍尔姆斯是硅谷的宠儿,受到了潜在投资者和技术巨头们的正面报道和极大关注。正如贝宝(PayPal)等公司彻底改变了停滞不前的支付行业,优步(Uber)颠覆了出租车行业一样,Theranos 也被定位为最新的科技公司,将大幅颠覆另一个成熟行业:医学实验室行业。舒尔茨的祖父、德高望重的美国前国务卿乔治-舒尔茨(George Shultz)是 Theranos 董事会成员,也是伊丽莎白-霍尔姆斯(Elizabeth Holmes)最大的支持者之一,这让舒尔茨的处境雪上加霜。但泰勒-舒尔茨担心的是,他确信客户收到的血液检测结果非常不可靠,而且往往不准确。由于事关重大,舒尔茨不知道自己应该如何行事。他应该向公司的投资者提出自己的担忧吗?对外揭发?向行业监管机构报告?本案例及其后四个简短的后续案例主要基于对泰勒-舒尔茨的访谈,概述了他所面临的两难境地,以及他将采取的各种措施,既要让自己摆脱不光彩的处境,又要让公众了解 Theranos 公司欺骗行为的全貌。如果课堂时间允许,这些讲义可作为学生的额外决策点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信